BPC-157 + KPV

BPC-157 component

KPV component

KPV is the C-terminal tripeptide of alpha-MSH (residues 11–13) and is one of the smallest peptides with documented anti-inflammatory activity in cell models. Published work reports interference with NF-kappa B nuclear translocation and reduced output of cytokines such as TNF-alpha and IL-6 in intestinal epithelial cultures, along with reports that intestinal cells take it up through the PepT1 transporter — a mechanism of interest in gut-targeted studies.

Why the two are combined

• Distinct mechanisms: matrix and angiogenic endpoints from BPC-157, transcription-factor and cytokine endpoints from KPV.
• Both are water-soluble and stable enough to share one lyophilized formulation without known incompatibility.
• The overlapping gastrointestinal literature makes them convenient to assay in a single model.

Evidence limits

Keep sealed vials at −20 °C, shielded from light and moisture, and let a vial reach room temperature before opening so condensation does not settle on the powder. Swab the stopper with 70% isopropyl alcohol, then add bacteriostatic or sterile water slowly down the inner wall and swirl gently until the cake dissolves; do not shake or vortex, since foaming shears peptides and traps material on the stopper. Because the two peptides share a vial, the reconstituted concentration applies to both at the stated ratio. Store the solution at 2–8 °C in the dark, label it with the concentration, lot and date, and inspect for cloudiness or particulates before each use.